Mineralocorticoid receptor and cardiovascular disease

M Buonafine, B Bonnard… - American Journal of …, 2018 - academic.oup.com
Activation of the mineralocorticoid receptor (MR) in the distal nephron by its ligand,
aldosterone, plays an important role in sodium reabsorption and blood pressure regulation …

Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease

A Nishiyama - Hypertension Research, 2019 - nature.com
Accumulating evidence has indicated the potential contributions of aldosterone and
mineralocorticoid receptor (MR) to the pathophysiology of cardiovascular disease (CVD) …

The role of the mineralocorticoid receptor in inflammation: focus on kidney and vasculature

Z Belden, JA Deiuliis, M Dobre… - American journal of …, 2017 - karger.com
Background: The remarkable success of clinical trials in mineralocorticoid receptor (MR)
inhibition in heart failure has driven research on the physiological and pathological role (s) …

Mineralocorticoid receptors in vascular function and disease

A McCurley, IZ Jaffe - Molecular and cellular endocrinology, 2012 - Elsevier
The mineralocorticoid receptor (MR), a member of the steroid receptor family, regulates
blood pressure by mediating the effects of the hormone aldosterone (Aldo) on renal sodium …

Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology

F Jaisser, N Farman - Pharmacological reviews, 2016 - ASPET
The mineralocorticoid receptor (MR) and its ligand aldosterone are the principal modulators
of hormone-regulated renal sodium reabsorption. In addition to the kidney, there are several …

Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis

MJ Young, AJ Rickard - Molecular and cellular endocrinology, 2012 - Elsevier
For 50years aldosterone has been thought to act primarily on epithelia to regulate fluid and
electrolyte homeostasis. Mineralocorticoid receptors (MR), however, are also expressed in …

Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms

J Bauersachs, A Lother - Kidney International Supplements, 2022 - Elsevier
Aldosterone controls salt–water homeostasis by acting on the mineralocorticoid receptor
(MR), a ligand-activated transcription factor, in kidney epithelial cells. However, it is now …

Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: from Hans Selye to the present

M Epstein - American journal of nephrology, 2021 - karger.com
Background: A full understanding of the mechanisms of action of aldosterone and its
interaction with the mineralocorticoid receptor (MR) allows a theoretical framework to predict …

[HTML][HTML] Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

JP Bertocchio, DG Warnock, F Jaisser - Kidney international, 2011 - Elsevier
Slowing the progression of chronic kidney diseases (CKDs) requires new and effective
treatment approaches. Aldosterone classically acts on the distal nephron: it facilitates …

[PDF][PDF] Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries.

D Sztechman, K Czarzasta… - Journal of Physiology …, 2018 - jpp.krakow.pl
In the review we discuss the role of mineralocorticoid receptors (MRs) in regulation and
pathological remodelling of the cardiovascular system and the therapeutic potential of …